查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439969

薦神經刺激器 - 全球市場回顧、競爭格局、市場預測（2030）

Sacral Nerve Stimulator Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計2023年全球薦神經刺激器市場規模將達10.6405億美元，2024-2030年預測期間複合年增長率為11.66%。薦神經刺激器的需求主要是由尿瀦留、急迫頻率和大便失禁的增加所驅動的。此外，創新先進技術的不斷採用、對微創治療方法的需求不斷增加、產品上市和批准增加等正在推動2024-2030年預測期內薦神經刺激器市場的整體成長。

薦神經刺激器市場動態

由於膀胱過動症（OAB）、尿失禁、大便失禁、前列腺癌等病例的增加，薦神經刺激器市場的產品需求正在積極增長。這些疾病會因尿失禁或大便失禁而乾擾人們的正常生活方式。因此，薦神經刺激器可以顯著減少或消除膀胱和腸道控制問題。例如，根據美國臨床腫瘤學會估計，到 2022 年，美國將有近 268,490 名男性被診斷出罹患攝護腺癌。據同一消息來源稱，估計 2020 年全球約有 1,414,259 名男性被診斷出患有前列腺癌。攝護腺癌是男性最常見的癌症。攝護腺癌會引起尿滯留和急迫性尿失禁等併發症，讓人感到不舒服。尿瀦留或急迫性尿失禁可以藉助骶神經刺激器來控制，該刺激器可以感知排尿的緊迫性並向大腦發送訊號。因此，前列腺癌病例數量的增加可能會增加市場對骶神經刺激器的需求。

此外，泌尿功能障礙、尿失禁、大便失禁等疾病在老年族群中也很常見。由於老化與影響肌肉鬆弛的心理社會因素的增加有關，因此 60 歲以上的人患上述疾病的風險增加。根據世界衛生組織（WHO）（2022）的預測，到2030年，全球六分之一的人將超過60歲。此時，60歲及以上人口比例將從2020年的10億增加到2030年的14億。此外，到2050年，全球60歲及以上的人口將翻倍，達到近21億人。根據相同統計數據，預計 2020 年至 2050 年間，全球 80 歲及以上人口數量將增加兩倍，達到 4.26 億。因此，不斷增長的老年人口面臨尿失禁和膀胱功能障礙的高風險，可以透過使用薦神經刺激器來控制。這是因為薦神經刺激器可以感知膀胱並向大腦發送依時排尿的信號。因此，老年人口的增加可能會增加對骶神經刺激器的需求，從而推動整體市場的成長。

因此，上述因素正在促進2024-2030年預測期內薦神經刺激器市場的成長。

然而，與植入設備相關的併發症可能會限制薦神經刺激器市場的成長。

在 COVID-19 大流行期間，薦神經刺激器市場受到了負面影響。疫情的爆發導致門診取消、非緊急醫院就診、外科手術取消。此外，由於優先考慮治療 COVID-19 患者，許多擇期手術被推遲。此外，供應鍊和原料限制導致設備製造停滯，導致市場設備短缺。然而，COVID-19疫苗的開發引發了經濟復甦。此外，隨著封鎖措施的放鬆和經濟狀況的正常化，各種慢性疾病的門診、手術等正常醫療服務的恢復，導致薦神經刺激器市場的成長，產品需求步入正軌。

本報告提供了全球薦神經刺激器市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章 薦神經刺激器市場報告簡介

第二章薦神經刺激器市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章薦神經刺激器市場關鍵因素分析

  • 薦神經刺激器市場的驅動因素
  • 薦神經刺激器市場限制與挑戰
  • 薦神經刺激器市場機會

第五章 薦神經刺激器市場波特五力分析

第六章 COVID-19 對薦神經刺激器市場的影響分析

第七章 薦神經刺激器市場佈局

  • 依產品
    • 植入式神經刺激器
    • 外部神經刺激器
  • 依用途
    • 膀胱過動症
    • 尿失禁、急迫性尿失禁
    • 非阻塞性尿滯留
    • 慢性大便失禁
    • 其他
  • 依最終用戶
    • 醫院
    • 門診手術中心
  • 區域
    • 北美薦神經刺激器市場規模（2021-2030）
    • 歐洲薦神經刺激器市場規模（2021-2030）
    • 亞太地區薦神經刺激器市場規模（2021-2030）
    • 其他地區性薦神經刺激器市場規模（2021-2030年）

第八章薦神經刺激器市場公司與產品概況

  • Medtronic
  • Axonics, Inc.
  • Boston Scientific Corporation
  • .NeuroPace, Inc.
  • Laborie.
  • Biegler GmbH
  • Finetech Medical

第9章 KOL觀點

第10章項目方法

第 11 章關於 DelveInsight

第十二章 免責聲明與聯絡我們

Product Code: DIMDCL0650

Sacral Nerve Stimulator Devices Market By Product (Implantable Nerve Stimulator And External Nerve Stimulator), By Application (Overactive Bladder, Urinary Or Bowel Urge Incontinence, Chronic Fecal Incontinence, And Others), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of overactive bladder and urge incontinence and the rising technological advancements

The global sacral nerve stimulator devices market was valued at USD 1,064.05 million in 2023, growing at a CAGR of 11.66% during the forecast period from 2024 to 2030. The demand for sacral nerve stimulator devices is primarily being boosted by the increasing figures for urinary retention, urgency frequency, fecal incontinence, and others. Further, the rising adoption of advanced and innovative technologies, the rising demand for minimally invasive treatment approaches, and the increasing product launches and approval among others are thereby contributing to the overall growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.

Sacral Nerve Stimulator Devices Market Dynamics:

The sacral nerve stimulator devices market is witnessing a positive growth in product demand due to the increasing cases of overactive bladder (OAB), urine & fecal incontinence, prostate cancer, and others. These diseases may disturb the normal lifestyle of a person owing to incontinence of urine and stool. Thus, a sacral nerve stimulator can greatly reduce or eliminate bladder and bowel control problems. For instance, according to American Society of Clinical Oncology 2022, it was estimated that in 2022 nearly 268,490 men in the United States were diagnosed with prostate cancer. As per the same source, it was estimated that approximately 1,414,259 men were diagnosed with prostate cancer worldwide in 2020. Prostate cancer is the most common cancer among men. Prostate cancer causes complications like urinary retention and urges incontinence which makes a person uncomfortable. Urinary retention or urge incontinence can be controlled with the help of a sacral nerve stimulator that senses the urgency of urination and send the signal to the brain. Thus, the increasing cases of prostate cancer may increase the demand for sacral nerve stimulators in the market.

Further, voiding dysfunction, urinary incontinence, fecal incontinence, and other diseases are very common in the older population. People more than 60 years are at a higher risk of developing the afore-said diseases as aging is associated with the increasing prevalence of psychosocial factors which affect the loosening of muscles. As per World Health Organization (WHO) 2022, it is predicted that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030, worldwide. Moreover, by 2050, the world's population of people aged 60 years and older will double which is nearly 2.1 billion. The statistics provided by the same source stated that the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, globally. Thus, the increasing geriatric population will be at high risk of urinary incontinence and bladder dysfunction which can be controlled by using a sacral nerve stimulator as sacral nerve stimulator can sense the bladder and send a signal to the brain for urination on time. Thus, the increasing geriatric population may increase the demand for sacral nerve stimulators, thereby propelling the overall market growth.

Therefore, the above-mentioned factors are contributing to the growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.

However, complications related to implantable devices, and others may restrict the sacral nerve stimulator devices market growth.

The sacral nerve stimulator market was negatively impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits, the suspension of non-emergency hospital visits, and the cancellation of surgical procedures. Moreover, many elective surgeries were postponed as treatment of patients suffering from coronavirus infection was on priority. Additionally, the restrictions on the supply chain, raw materials, and other resources halted the manufacturing of devices, leading to a shortage of devices in the market. However, the vaccine development of COVID-19 initiated the process of economic recovery. Also, the easing of lockdown restrictions and the return of normalcy in the economic landscape initiated the process of resumption of regular healthcare services such as outpatient visits and surgeries for the treatment of various chronic ailments, thereby bringing the demand for products on track in the sacral nerve stimulator market.

Sacral Nerve Stimulator Devices Market Segment Analysis:

Sacral nerve stimulator devices by Product (Implantable Nerve Stimulator and External Nerve Stimulator), Application (Overactive Bladder (OAB), Urinary or Bowel Urge Incontinence, Chronic Fecal Incontinence, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the sacral nerve stimulator devices market, the implantable nerve stimulator category is expected to amass significant revenue share in the year 2023. This can be ascribed to the advantages offered by the segment.

For instance, the advantages of implantable sacral nerve stimulators over other products include quicker signal response, less discomfort, minimal invasion, and shorter operating times.

The increasing prevalence of OAB, urine & fecal incontinence, and others may also increase the demand for implantable nerve stimulators.

OAB may affect relationships with friends and family. It can disrupt a person's sleep & sex life and can leave anyone tired and depressed. OAB can lead to urge incontinence, urinating frequent, nocturia, and others. An implantable nerve stimulator can be used to sense quicker urine urgency and can send a signal of the urgency to the brain which may aid in curing the symptoms of urinary incontinence. Thus, the increasing demand for sacral nerve stimulators for the treatment of OAB may lead to an increased demand for implantable nerve stimulator devices.

Furthermore, the increasing awareness regarding sacral nerve stimulators, product launches, and approvals are also a factor for the implantable sacral nerve stimulator market growth. For instance, in 2022, the Axonics F15 device was cleared by the FDA, allowing it to be implanted for upward of 15 years to block the abnormal nerve signals linked to overactive bladder and fecal incontinence.

Therefore, the advantages offered by implantable sacral nerve stimulators are predicted to contribute to the increasing demand for this product thereby driving the growth of the overall sacral nerve stimulator devices market during the forecast period.

North America is expected to dominate the overall Sacral Nerve Stimulator Devices Market:

Among all the regions, North America is estimated to account for the largest share of the sacral nerve stimulator devices market in the year 2023. Factors such as the growing prevalence of urine & fecal incontinence and the increasing cases of OAB are driving the North America sacral nerve stimulator devices market. Further, the increasing geriatric population, the high disposable income, the sophisticated healthcare infrastructure, the regulatory approval for new devices, and the high awareness about the devices also helped the market growth in this region.

Further, people who have urinary retention may have complications, including urinary tract infection (UTI), bladder damage, and kidney damage. According to the Urology Care Foundation 2020, UTIs are very common in the US. In premenopausal women, an annual estimated incidence of UTI is 0.5 - 0.7 per person reported in the US, yearly.

Further, various studies have stated that sacral neuromodulator (SNM) has a positive therapeutic effect on the lower urinary tract and has shown to be an effective treatment for UTI. The urinary tract infection may cause urge incontinence and these patients may require sacral nerve stimulators.

Moreover, the device can also be discontinued at any time without any permanent damage to the nerve. Thus, the increasing number of cases of UTI may increase the number of urinary incontinence cases, ultimately increasing the demand for sacral nerve stimulators, thereby increasing the overall market in the region.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in February 2022 Medtronic plc, a global leader in healthcare technology, received approval from the US Food and Drug Administration (FDA) for InterStim X(TM), the next generation of the InterStim(TM) portfolio's recharge-free neurostimulation device, which offers more than 10 years of battery life without the need to recharge, providing patients with more freedom and less maintenance. Thus, such strategic steps help to increase the demand for sacral nerve stimulator devices, thereby driving the North American sacral nerve stimulator devices market forward during the forecast period.

Sacral Nerve Stimulator Devices Market Key Players:

Some of the key market players operating in the sacral nerve stimulator devices market include Medtronic, Axonics, Inc., Boston Scientific Corporation, NeuroPace, Inc., Laborie, Biegler GmbH, Finetech Medical, and others.

Recent Developmental Activities in the Sacral Nerve Stimulator Devices Market:

In February 2023, the US FDA approved Axonics Inc's 4th-generation rechargeable neurostimulator for the treatment of fecal incontinence and overactive bladder.

In August 2021, in the US Finetech-Brindley, a bladder control system was launched as an active implantable medical device and is intended for restoration of bladder function after a complete spinal cord injury. Later the Finetech Brindley bladder control system is named academically as a sacral anterior root stimulator. It is an external, wireless device used to control the implant and its function.

Key Takeaways from the Sacral Nerve Stimulator Devices Market Report Study

Market size analysis for current sacral nerve stimulator devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the sacral nerve stimulator devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global sacral nerve stimulator devices market.

Various opportunities available for the other competitor in the sacral nerve stimulator devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current sacral nerve stimulator devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for sacral nerve stimulator devices market growth in the coming future?

Target Audience who can be benefited from this Sacral Nerve Stimulator Devices Market Report Study

Sacral nerve stimulator devices products providers

Research organizations and consulting companies

Sacral nerve stimulator device s-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in sacral nerve stimulator devices

Various End-users who want to know more about the sacral nerve stimulator devices market and the latest technological developments in the sacral nerve stimulator devices market.

Frequently Asked Questions for the Sacral Nerve Stimulator Devices Market:

1. What are sacral nerve stimulator devices?

The sacral nerve stimulator delivers gentle electrical impulses through a probe (a thin wire) that is placed near the sacral nerve thereby stimulating the bowel and bladder muscles to work normally.

2. What is the market for global sacral nerve stimulator devices?

The global sacral nerve stimulator devices market was valued at USD 1,064.05 million in 2023, growing at a CAGR of 11.66% during the forecast period from 2024 to 2030.

3. What are the drivers for global sacral nerve stimulator devices market?

The demand for sacral nerve stimulator devices is primarily being heightened by the increasing prevalence of overactive bladder, increasing cases of urge incontinence & fecal incontinence, the rising prevalence of prostate cancer, and others. In addition, the advancement in sacral nerve stimulator devices, and the increasing device launches and approvals among others are thereby contributing to the overall growth of the sacral nerve stimulator devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global sacral nerve stimulator devices market?

Some of the key market players operating in the sacral nerve stimulator devices market include Medtronic, Axonics, Inc., Boston Scientific Corporation, NeuroPace, Inc., Laborie, Biegler GmbH, Finetech Medical, and others.

5. Which region has the highest share in the sacral nerve stimulator devices market?

North America is expected to dominate the overall sacral nerve stimulator devices market during the forecast period from 2024-2030. Factors such as the rising prevalence of overactive bladder conditions (OAB) and urge incontinence, the increasing geriatric population, the growing demand for non-invasive treatment, and other factors aid in the growth of the sacral nerve stimulator market in North America. Furthermore, high disposable income, sophisticated healthcare infrastructure, and regulatory approval for new devices also helped the market growth in this region.

Table of Contents

1. Sacral Nerve Stimulator Device Market Report Introduction

2. Sacral Nerve Stimulator Device Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Sacral Nerve Stimulator Device Market Key Factors Analysis

  • 4.1. Sacral Nerve Stimulator Device Market Drivers
    • 4.1.1. Increasing Prevalence of overactive bladder and fecal incontinence
    • 4.1.2. Increasing health issues in the geriatric population and increasing risk factors such as obesity, diabetes, hypertension
  • 4.2. Sacral Nerve Stimulator Device Market Restraints and Challenges
    • 4.2.1. Side effects associated with the device
  • 4.3. Sacral Nerve Stimulator Device Market Opportunities
    • 4.3.1. Rising research and development activity for wearable sacral nerve stimulator

5. Sacral Nerve Stimulator Device Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Sacral Nerve Stimulator Device Market

7. Sacral Nerve Stimulator Device Market Layout

  • 7.1. By Product
    • 7.1.1. Implantable nerve stimulator
    • 7.1.2. External nerve stimulator
  • 7.2. By Application
    • 7.2.1. Overactive bladder
    • 7.2.2. Urinary or bowel urge incontinence
    • 7.2.3. Non-obstructive urinary retention
    • 7.2.4. Chronic fecal incontinence
    • 7.2.5. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.1.1. United States sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.2. Europe Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.2.1. France Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.3.1. China Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.3.3. India Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW) Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.4.1. Middle East Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Sacral Nerve Stimulator Device Market Size in USD million (2021-2030)

8. Sacral Nerve Stimulator Device Market Company and Product Profiles

  • 8.1. Medtronic
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Axonics, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Boston Scientific Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4 .NeuroPace, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Laborie.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Biegler GmbH
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Finetech Medical
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Sacral Nerve Stimulator Device Market in Global (2021-2030)
  • Table 4: Sacral Nerve Stimulator Device Market in Global by Product (2021-2030)
  • Table 5: Sacral Nerve Stimulator Device Market in Global by Application (2021-2030)
  • Table 6: Sacral Nerve Stimulator Device Market in Global by End-User (2021-2030)
  • Table 7: Sacral Nerve Stimulator Device Market in Global by Geography (2021-2030)
  • Table 8: Sacral Nerve Stimulator Device Market in North America (2021-2030)
  • Table 9: Sacral Nerve Stimulator Device Market in North America by Country (2021-2030)
  • Table 10: Sacral Nerve Stimulator Device Market in the US (2021-2030)
  • Table 11: Sacral Nerve Stimulator Device Market in Canada (2021-2030)
  • Table 12: Sacral Nerve Stimulator Device Market in Mexico (2021-2030)
  • Table 13: Sacral Nerve Stimulator Device Market in Europe (2021-2030)
  • Table 14: Sacral Nerve Stimulator Device Market in Europe by Country (2021-2030)
  • Table 15: Sacral Nerve Stimulator Device Market in France (2021-2030)
  • Table 16: Sacral Nerve Stimulator Device Market in Germany (2021-2030)
  • Table 17: Sacral Nerve Stimulator Device Market in the United Kingdom (2021-2030)
  • Table 18: Sacral Nerve Stimulator Device Market in Italy (2021-2030)
  • Table 19: Sacral Nerve Stimulator Device Market in Spain (2021-2030)
  • Table 20: Sacral Nerve Stimulator Device Market in the Rest of Europe (2021-2030)
  • Table 21: Sacral Nerve Stimulator Device Market in Asia-Pacific (2021-2030)
  • Table 22: Sacral Nerve Stimulator Device Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Sacral Nerve Stimulator Device Market in China (2021-2030)
  • Table 24: Sacral Nerve Stimulator Device Market in Japan (2021-2030)
  • Table 25: Sacral Nerve Stimulator Device Market in India (2021-2030)
  • Table 26: Sacral Nerve Stimulator Device Market in Australia (2021-2030)
  • Table 27: Sacral Nerve Stimulator Device Market in South Korea (2021-2030)
  • Table 28: Sacral Nerve Stimulator Device Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Sacral Nerve Stimulator Device Market in the Rest of the World (2021-2030)
  • Table 30: Sacral Nerve Stimulator Device Market in RoW by Region (2021-2030)
  • Table 31: Sacral Nerve Stimulator Device Market in the Middle East (2021-2030)
  • Table 32: Sacral Nerve Stimulator Device Market in Africa (2021-2030)
  • Table 33: Sacral Nerve Stimulator Device Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Sacral Nerve Stimulator Device Market in Global (2021-2030)
  • Figure 4: Sacral Nerve Stimulator Device Market in Global by Product (2021-2030)
  • Figure 5: Sacral Nerve Stimulator Device Market in Global by Application (2021-2030)
  • Figure 6: Sacral Nerve Stimulator Device Market in Global by End-User (2021-2030)
  • Figure 7: Sacral Nerve Stimulator Device Market in Global by Geography (2021-2030)
  • Figure 8: Sacral Nerve Stimulator Device Market in North America (2021-2030)
  • Figure 9: Sacral Nerve Stimulator Device Market in North America by Country (2021-2030)
  • Figure 10: Sacral Nerve Stimulator Device Market in the US (2021-2030)
  • Figure 11: Sacral Nerve Stimulator Device Market in Canada (2021-2030)
  • Figure 12: Sacral Nerve Stimulator Device Market in Mexico (2021-2030)
  • Figure 13: Sacral Nerve Stimulator Device Market in Europe (2021-2030)
  • Figure 14: Sacral Nerve Stimulator Device Market in Europe by Country (2021-2030)
  • Figure 15: Sacral Nerve Stimulator Device Market in France (2021-2030)
  • Figure 16: Sacral Nerve Stimulator Device Market in Germany (2021-2030)
  • Figure 17: Sacral Nerve Stimulator Device Market in the United Kingdom (2021-2030)
  • Figure 18: Sacral Nerve Stimulator Device Market in Italy (2021-2030)
  • Figure 19: Sacral Nerve Stimulator Device Market in Spain (2021-2030)
  • Figure 20: Sacral Nerve Stimulator Device Market in the Rest of Europe (2021-2030)
  • Figure 21: Sacral Nerve Stimulator Device Market in Asia-Pacific (2021-2030)
  • Figure 22: Sacral Nerve Stimulator Device Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Sacral Nerve Stimulator Device Market in China (2021-2030)
  • Figure 24: Sacral Nerve Stimulator Device Market in Japan (2021-2030)
  • Figure 25: Sacral Nerve Stimulator Device Market in India (2021-2030)
  • Figure 26: Sacral Nerve Stimulator Device Market in Australia (2021-2030)
  • Figure 27: Sacral Nerve Stimulator Device Market in South Korea (2021-2030)
  • Figure 28: Sacral Nerve Stimulator Device Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Sacral Nerve Stimulator Device Market in the Rest of the World (2021-2030)
  • Figure 30: Sacral Nerve Stimulator Device Market in RoW by Region (2021-2030)
  • Figure 31: Sacral Nerve Stimulator Device Market in the Middle East (2021-2030)
  • Figure 32: Sacral Nerve Stimulator Device Market in Africa (2021-2030)
  • Figure 33: Sacral Nerve Stimulator Device Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis